MedPath
NMPA Approval

Ribavirin Injection

国药准字H22022844

August 19, 2021

国药准字H22022844

Drug Information

利巴韦林注射液

注射剂

1ml:100mg

化学药品

August 19, 2021

Company Information

Applicant Company

吉林市高新区深圳街95号

Manufacturing Company

吉林市高新区深圳街95号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利巴韦林注射液 - NMPA 批准文号 | MedPath